Trial reportFrontiers in urology2025
Global, regional, and national burdens of Urolithiasis in adolescents and young adults aged 10-24 years from 1990 to 2021: a trend analysis based on the Global Burden of Disease Study 2021.
Trial report in Frontiers in urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Global, Regional, and National Burden of Acute Abdominal Conditions in Females-Appendicitis, Ectopic Pregnancy, Paralytic Ileus and Intestinal Obstruction, and Urolithiasis, 1990-2021: A Systematic Analysis for the Global Burden of Disease Study 2021 with ARIMA Projections to 2030.International journal of women's health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Urolithiasis poses a significant health risk to adolescents worldwide, yet information on its burden and trends is limited. This study analyzed the evolving patterns of urolithiasis among 10-24-year-olds globally, regionally, and nationally from 1990 to 2021. Methods: This study predicted the global burden of diseases and investigated urolithiasis incidence and disability-adjusted life-years (DALYs) in 10-24-year-olds. We reported cases, rates per 100,000, and AAPCs globally, regionally, and nationally. We explored trends across age groups, sexes, and SDI categories, using Joinpoint regression to identify the year with the most significant global trend shift. Results: The global incidence of urolithiasis among adolescents and young adults aged 10 - 24 years has increased modestly, from 321.5 per 100,000 in 1990 to 342.6 per 100,000 in 2021, with an average annual percent change (AAPC) of 0.2. A significant upward shift was observed in 2009. Regionally, Tropical Latin America saw the largest increase, with a rise from 155.1 per 100,000 in 1990 to 296.4 per 100,000 in 2021, and an AAPC of 2.07. In contrast, East Asia experienced the most significant decline, dropping from 214.2 per 100,000 in 1990 to 140.2 per 100,000 in 2021, with an AAPC of -1.37. Nationally, Brazil showed the highest increase, with an AAPC of 2.14, while the Russian Federation had the highest incidence in 2021, at 812.7 per 100,000. The middle-SDI quintile countries saw the largest increase in incidence, with an AAPC of 0.45. However, countries with high to middle and high SDI scores demonstrated a decrease in incidence. From 1990 to 2021, the incidence of urolithiasis increased more rapidly among females than males, with an AAPC of 0.26 and 0.16 respectively. By 2021, there were 6,467,487 cases globally, 57.8% of which were in males. The most significant increase in incidence was observed among those aged 20 - 24 years, with an AAPC of 0.29. Conclusions: The global burden of urolithiasis in adolescents and youth is a significant health issue requiring international collaboration for better management. Enhancing diagnostic tools and implementing effective prevention and treatment methods are crucial.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.